Live tape
Top 8, mentions 7d9,906TSLA2,156 mentions▲ +0.05GOOGL1,383 mentions▲ +0.04CRWV1,317 mentions▲ +0.03SPCX1,215 mentions▲ +0.06NVDA1,142 mentions▲ +0.07QQQ1,061 mentions▲ +0.04NBIS851 mentions▲ +0.06META781 mentions▲ +0.05

Equity · Healthcare

USPH

NYSE

U.S. Physical Therapy, Inc.

$74 0.00% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for USPH to draw a line in its place.

Market cap $1.1B
P/E (TTM) 435.3
52-week range $59 – $93.03
Avg volume 40.6K

as of Jul 17, 2026

USPH insider trades

SEC Form 4

USPH has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 24 November 2025.

Date Insider Type Shares Value
24 Nov 2025 REEVE GRAHAM D. COO Sell 743 $53K
20 Nov 2025 Gilmartin Kathleen A Buy 4,000 $276K

USPH reported financials

SEC EDGAR XBRL SEC EDGAR

USPH reported revenue of $781.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was $39.6M.

Figure Reported Period
Revenue $781.0M 31 Dec 2025 fiscal year
Net income $39.6M 31 Dec 2025 fiscal year
Diluted EPS $1.42 31 Dec 2025 fiscal year
Total assets $1.2B 30 Jun 2026 at period end
Total equity $448.7M 30 Jun 2026 at period end

USPH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.25 $214M
31 Mar 2026 Q1 2026 −$0.12 $198M
31 Dec 2025 FY 2025 $1.42 $781M
30 Sep 2025 Q3 2025 $0.48 $197M
30 Jun 2025 Q2 2025 $0.58 $197M
31 Mar 2025 Q1 2025 $0.80 $184M
31 Dec 2024 FY 2024 $1.84 $671M
30 Sep 2024 Q3 2024 $0.39 $168M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

USPH institutional holders

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a USPH position for the quarter ended 30 Jun 2026 — a combined $33.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) +7.8% shares 110,585 $7.6M
Citadel Advisors Added +704.4% shares 82,053 $5.6M
Renaissance Technologies Held (±25%) −7.7% shares 70,997 $4.9M
Marshall Wace Added +167.8% shares 68,453 $4.7M
Balyasny Asset Management Added +92.8% shares 37,362 $2.6M
Millennium Management Added +1,227.9% shares 36,424 $2.5M
Point72 Asset Management Trimmed −86.2% shares 33,223 $2.3M
Tudor Investment Corp Added +422.9% shares 21,877 $1.5M
AQR Capital Management Held (±25%) +10.3% shares 19,835 $1.4M
Man Group Exited

USPH fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 312 shares of USPH failed to deliver (about $27K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 312 $27K 0.002%
28 Sep 2026 7 $594 <0.001%
24 Sep 2026 2 $165 <0.001%
23 Sep 2026 82 $7K 0.001%
22 Sep 2026 2,258 $186K 0.015%
16 Sep 2026 750 $61K 0.005%
15 Sep 2026 1 $81 <0.001%

Congressional trades in USPH

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in USPH is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 20 May 2025.

Date Member Type Amount
20 May 2025 filed 06 Jun 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
17 Apr 2025 filed 14 May 2025 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
29 Jan 2025 filed 11 Feb 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
17 Oct 2024 filed 06 Nov 2024 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
16 Sep 2024 filed 03 Oct 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
24 May 2023 filed 11 Jun 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings